XTRA:PUM
XTRA:PUMLuxury

Should Investors Rethink PUMA After a 52% Drop in 2025?

Thinking about what to do with PUMA stock? You are definitely not alone; this name has been on the radar for investors trying to make sense of shifting markets, fresh headlines, and some dramatic swings in share price. Over the short term, PUMA’s stock has been a bit of a rollercoaster, dropping 2.4% over the past week after a moderate 3.0% gain last month. But zoom out, and the numbers paint an even starker picture. Year-to-date, the stock is down a hefty 52.0%, and over the last twelve...
NasdaqCM:EXAS
NasdaqCM:EXASBiotechs

Is There Now an Opportunity in Exact Sciences After Its 18% Price Surge?

Thinking of what to do with Exact Sciences stock? You are not alone. Many investors are weighing their options after some notable swings in both the price and the risk perceptions around this innovative diagnostics company. Over the past month, shares have climbed an impressive 18.2%, setting a fresh tone of optimism that follows a more sluggish 1-year return of -9.1%. Looking further back, the company has delivered an 81.9% return over three years, underscoring that there is potential for...
NasdaqGS:INTC
NasdaqGS:INTCSemiconductor

Why Intel (INTC) Is Up 8.9% After Strong Q3 Earnings and New AI Partnership

In the past week, Intel reported third-quarter 2025 earnings that exceeded expectations, with net income of US$4.06 billion reversing a prior-year loss and revenue rising to US$13.65 billion. TurinTech announced a collaboration with Intel, aiming to bring AI engineering platform Artemis to Intel systems, underscoring Intel's increasing focus on AI solutions and workload optimization. We'll explore how Intel's recent AI-focused partnerships, like the TurinTech collaboration, could influence...
NasdaqGS:MQ
NasdaqGS:MQDiversified Financial

Can Marqeta’s (MQ) Leadership Shift Illuminate Its Approach to Revenue Concentration Risks?

In late October 2025, Marqeta appointed Sarah Barkema as Principal Accounting Officer, shifting responsibilities from CEO and CFO Mike Milotich, amid recent analyst downgrades highlighting concerns about customer concentration and growth prospects. This leadership change, combined with cautious analyst commentary, reflects market concerns about Marqeta’s revenue stability and long-term diversification. To assess the impact of these developments, we'll examine how executive leadership changes...
NasdaqGM:WVE
NasdaqGM:WVEPharmaceuticals

How Investors May Respond To Wave Life Sciences (WVE) Advancing RNA Therapies for Rare Diseases and Obesity

Wave Life Sciences recently announced updates on multiple ongoing clinical studies, including promising advancements in RNA-based treatments targeting alpha-1 antitrypsin deficiency, Duchenne Muscular Dystrophy, and obesity. These developments highlight a growing focus on RNA editing and oligonucleotide therapeutics as the company expands its footprint in the precision medicine landscape. We'll explore how these positive clinical trial updates, especially in RNA-based therapies for rare...
NYSE:ETR
NYSE:ETRElectric Utilities

Entergy (ETR): Valuation in Focus After RBC Capital Reinstates Coverage With Outperform Rating

Entergy (ETR) shares have drawn extra attention after RBC Capital reinstated coverage with an Outperform rating. This signals renewed confidence in the company’s outlook and has prompted some investors to take another look at its valuation. See our latest analysis for Entergy. Entergy’s share price has been making a steady comeback, notching a 26% gain year to date while marking a remarkable 45.9% total shareholder return over the past year. Recent bullish analyst sentiment and positive...
NYSE:BBBY
NYSE:BBBYSpecialty Retail

Bed Bath & Beyond (BBBY): Losses Worsen at 59.6% Annual Rate, Challenging Value Narrative

Bed Bath & Beyond (BBBY) remains deeply in the red, with losses accelerating by an average of 59.6% per year over the past five years. While revenue is forecast to grow 7.5% annually, this trails the broader US market's expected 10.1% per year and profits are not expected for at least the next three years. Despite the company trading at a price-to-sales multiple of 0.5x versus a sector average of 0.7x, persistent unprofitability and recent share dilution keep investor sentiment cautious. See...
NYSE:CRH
NYSE:CRHBasic Materials

Should Analyst Optimism and US$80 Billion Milestone Prompt a Closer Look at CRH's (CRH) Growth Story?

In the past week, several analysts reiterated their positive views on CRH plc following its recent Investor Day, highlighting strong market positioning and growth drivers such as infrastructure and data centre demand. An important insight is that CRH’s market capitalization surpassed US$80 billion following the event, underscoring how investor enthusiasm is being bolstered by both analyst coverage and company updates. We'll explore how this wave of analyst optimism after Capital Markets Day...
NYSE:RVLV
NYSE:RVLVSpecialty Retail

Revolve Group (RVLV): Examining Valuation After Recent Share Price Momentum

Revolve Group (RVLV) shares have moved slightly lower in recent trading, giving investors a reason to revisit the company’s performance. Over the past month, the stock has gained 7%, which offers some perspective on current momentum. See our latest analysis for Revolve Group. Looking beyond the recent uptick, Revolve Group’s 30-day share price return of 6.6% suggests momentum may be returning, even as the year-to-date performance remains deep in the red at -30.1%. Over the past year, total...
NYSE:LDOS
NYSE:LDOSProfessional Services

Leidos Holdings Shares Surge 31% in 2025 Amid Cybersecurity Contract Wins

If you're weighing what to do with your Leidos Holdings shares, you're not alone. With the stock closing recently at $187.81, it's natural to wonder if now is the right time to buy, hold, or even step away. The numbers certainly catch the eye: while the past week has seen a slight retreat of -2.8%, Leidos is up 1.6% over the last month, and an impressive 31.1% year to date. The longer-term picture pops even more, with a whopping 128.1% return over five years. That kind of growth attracts...
TSX:PSD
TSX:PSDEnergy Services

Pulse Seismic (TSX:PSD) Profit Margin Surges, Reinforcing Bullish Community Narratives

Pulse Seismic (TSX:PSD) delivered a net profit margin of 44.4%, rising from 31.5% a year ago, while earnings increased by 103.4% over the past twelve months. Over the last five years, annual earnings growth averaged 30.9%, reinforcing a clear acceleration in profit momentum for investors to consider. See our full analysis for Pulse Seismic. The real question is how these headline numbers compare with the most widely followed market narratives. Let’s dive in and see which stories are...
NYSE:OSCR
NYSE:OSCRInsurance

Oscar Health (OSCR): Is the Growing Product Pipeline Reflected in Its Current Valuation?

Oscar Health (NYSE:OSCR) just announced a wave of new health plan offerings, highlighted by Oswell, its first personal AI agent, and HelloMeno, the inaugural menopause-focused plan in the ACA marketplace. The company is also expanding into new regions and employer markets. See our latest analysis for Oscar Health. All this new product momentum comes on the heels of a strong run for Oscar Health's shares, with a 90-day share price return of nearly 40% and a year-to-date gain of 44%. Looking...
NYSE:NET
NYSE:NETIT

Could Cloudflare's (NET) Blockchain Bet Reveal Its Next Competitive Edge in Cloud and Payments?

Earlier this month, Cloudflare participated in the 1st Annual Austin C-Level Technology Leadership Summit, with Field CTO John Engates presenting and discussing industry innovation at the Austin Country Club in Texas. Cloudflare's recent support for the rapidly expanding x402 blockchain payment protocol, alongside speculation about sector M&A activity, has drawn fresh attention to its evolving position in cloud and payment technologies. We'll explore how Cloudflare's support of the...
NYSE:TX
NYSE:TXMetals and Mining

Can Ternium's (TX) Margin Discipline Offset Weak Market Demand Longer Term?

Ternium recently reported quarterly adjusted earnings of US$0.10 per share and an 11.7% revenue drop to US$3.96 billion, both missing analyst expectations, alongside guidance for a slight adjusted EBITDA decline in the next quarter due to seasonal shipment decreases. While management aims to maintain EBITDA margins through cost reductions and operational efficiencies despite lower revenues in Mexico and Argentina, the cautious outlook highlights ongoing challenges for the company's core...
NYSE:MIR
NYSE:MIRElectronic

Mirion Technologies (MIR): Assessing Valuation After Strong Earnings, Guidance Reaffirmation, and Investor Momentum

Mirion Technologies (NYSE:MIR) released its third quarter results along with a confirmation of its full-year revenue outlook, showing both improved revenue and a return to profitability compared to last year. The update sheds light on recent investor attention. See our latest analysis for Mirion Technologies. Mirion’s recent financial updates have struck a chord with investors, underscored by the company’s 2.65% one-day share price return and a sustained 48.9% year-to-date share price gain...
NYSE:JOBY
NYSE:JOBYAirlines

Joby Aviation (JOBY): Unpacking Valuation as Certification Progress and Commercial Launch Plans Take Focus

Joby Aviation is about to take center stage as investors gear up for its third-quarter earnings. They are closely watching for updates regarding FAA certification and the company’s efforts to launch commercial operations in the UAE and U.S. in 2026. See our latest analysis for Joby Aviation. Recent months have been packed for Joby Aviation, from acquiring Blade’s passenger business to striking a defense partnership and landing a UAE air taxi agreement. Even with some short-term share price...
AIM:AMS
AIM:AMSMedical Equipment

UK Value Stocks Trading At Up To 49.1% Estimated Discount

The United Kingdom's stock market has recently faced challenges, with the FTSE 100 index closing lower due to weak trade data from China and declining commodity prices impacting key sectors. Amid these conditions, investors may find potential opportunities in undervalued stocks that offer a significant discount relative to their intrinsic value, providing a cushion against broader market volatility.